{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:20:42Z","timestamp":1791411642845,"version":"4.3.3"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","brachyjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.brachy.2024.04.004","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T14:27:19Z","timestamp":1717856839000},"page":"604-609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Re-treatment of locally recurrent uveal melanoma with repeat eye plaque I-125 brachytherapy: A single institution experience"],"prefix":"10.1016","volume":"23","author":[{"given":"Kevin","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4439-1870","authenticated-orcid":false,"given":"Amy C","family":"Schefler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Chevli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3833-6568","authenticated-orcid":false,"given":"Forrest","family":"Ivey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7006-8631","authenticated-orcid":false,"given":"Devin","family":"Olek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Bretana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4304-5201","authenticated-orcid":false,"given":"Ramiro","family":"Pino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward Brian","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin S.","family":"Teh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2024.04.004_bib0001","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.brachy.2024.04.004_bib0002","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41571-022-00714-1","article-title":"Advances in the clinical management of uveal melanoma","volume":"20","author":"Carvajal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.brachy.2024.04.004_bib0003","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/OPTH.S89591","article-title":"Uveal melanoma: epidemiology, etiology, and treatment of primary disease","volume":"11","author":"Krantz","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.brachy.2024.04.004_bib0004","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0197-2456(93)90052-F","article-title":"Design and methods of a clinical trial for a rare condition: the Collaborative Ocular Melanoma Study. COMS Report No. 3","volume":"14","author":"Diener-West","year":"1993","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.brachy.2024.04.004_bib0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5114\/jcb.2022.115210","article-title":"Contemporary trends in management of uveal melanoma","volume":"14","author":"Chevli","year":"2022","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2024.04.004_bib0006","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0161-6420(02)01277-0","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19 [published correction appears in Ophthalmology. 2004 Aug;111(8):1514]","volume":"109","author":"Jampol","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2024.04.004_bib0007","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archopht.119.7.969","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18","volume":"119","author":"Diener-West","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2024.04.004_bib0008","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5114\/jcb.2022.115379","article-title":"Three-year outcomes of uveal melanoma treated with intra-operative ultrasound-guided iodine-125 brachytherapy using custom-built eye plaques","volume":"14","author":"Wong","year":"2022","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2024.04.004_bib0009","unstructured":"Uveal M: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines \u00ae) NCCN.Org.; 2023. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/uveal.pdf (Accessed 2\/7\/2023)."},{"key":"10.1016\/j.brachy.2024.04.004_bib0010","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ajo.2014.07.013","article-title":"Salvage proton beam therapy in local recurrent uveal melanoma","volume":"158","author":"Riechardt","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.brachy.2024.04.004_bib0011","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.ijrobp.2005.09.035","article-title":"Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma","volume":"64","author":"Marucci","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.04.004_bib0012","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ijrobp.2009.12.018","article-title":"Uveal melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation","volume":"79","author":"Marucci","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.04.004_bib0013","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40942-018-0123-1","article-title":"Gamma knife radiosurgery for locally recurrent choroidal melanoma following plaque radiotherapy","volume":"4","author":"Sorour","year":"2018","journal-title":"Int J Retina Vitreous"},{"key":"10.1016\/j.brachy.2024.04.004_bib0014","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5114\/jcb.2019.82888","article-title":"Personalized re-treatment strategy for uveal melanoma local recurrences after interventional radiotherapy (brachytherapy): single institution experience and systematic literature review","volume":"11","author":"Tagliaferri","year":"2019","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2024.04.004_bib0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.brachy.2013.10.007","article-title":"Reirradiation of the eye with plaque brachytherapy: a single institution experience report of eight consecutive patients submitted to retreatment after local relapse of malignant disease of the eye","volume":"13","author":"Gaspar de Souza Neves","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.04.004_bib0016","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajo.2016.12.022","article-title":"Repeat episcleral plaque brachytherapy: clinical outcomes in patients treated for locally recurrent posterior uveal melanoma","volume":"176","author":"King","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.brachy.2024.04.004_bib0017","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ajo.2015.06.017","article-title":"Local recurrence after primary proton beam therapy in uveal melanoma: risk factors, retreatment approaches, and outcome","volume":"160","author":"Seibel","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.brachy.2024.04.004_bib0018","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijrobp.2005.01.022","article-title":"Radiation complications and tumor control after 125I plaque brachytherapy for ocular melanoma","volume":"63","author":"Jensen","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.04.004_bib0019","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.brachy.2018.07.002","article-title":"Outcomes of choroidal melanomas treated with eye physics plaques: a 25-year review","volume":"17","author":"Le","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.04.004_bib0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/IAE.0b013e3181863f7c","article-title":"Corneoscleral necrosis after episcleral Au-198 brachytherapy of uveal melanoma","volume":"29","author":"Chaudhry","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.brachy.2024.04.004_bib0021","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/S0161-6420(97)30025-6","article-title":"Metastatic risk for distinct patterns of postirradiation local recurrence of posterior uveal melanoma","volume":"104","author":"Harbour","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2024.04.004_bib0022","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ophtha.2015.09.014","article-title":"Local recurrence significantly increases the risk of metastatic uveal melanoma","volume":"123","author":"Gallie","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2024.04.004_bib0023","article-title":"The decisionDx-UM gene expression profile test provides risk stratification and individualized patient care in uveal melanoma","volume":"5","author":"Harbour","year":"2013","journal-title":"PLoS Curr"},{"key":"10.1016\/j.brachy.2024.04.004_bib0024","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.ophtha.2012.02.017","article-title":"Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma","volume":"119","author":"Onken","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2024.04.004_bib0025","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2353\/jmoldx.2010.090220","article-title":"An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma","volume":"12","author":"Onken","year":"2010","journal-title":"J Mol Diagn"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472124000680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472124000680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T00:01:12Z","timestamp":1724544072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472124000680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1538472124000680"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2024.04.004","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re-treatment of locally recurrent uveal melanoma with repeat eye plaque I-125 brachytherapy: A single institution experience","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2024.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}